Meet our CEO, Andrea Chicca, and CCO, Simon Russell, @Jefferies London Healthcare Conference next week, 14-16 November.
Please get in touch if you would like to meet with the @Synendos team at this important industry event.
#CNS#biotech#neuropsychiatry
@Synendos today announces that co-founder and SAB member Prof. Jürg Gertsch presented groundbreaking findings on an #endocannabinoid transporter at the 10th @GordonConf, informing and augmenting Synendos' pioneering ECS pipeline development.
Read more: https://t.co/Somn73pa6V
@Synendos is excited to support and participate in the 10th @GordonConf "Cannabinoids Function in the CNS" from 16-21st July 2023, with a talk from co-founder and scientific advisor member Prof. Jürg Gertsch.
#endocannabinoidsystem#CNS#Biotech
More info: https://t.co/ajpbeAbdmA
Our CEO & CSO Andrea Chicca will be speaking at BIO-Europe Spring 2023, March 21, 14:00 – 14:45 in Basel.
He will be the part of session “Navigating the Roadblocks of Biotech Entrepreneurship: Strategies for Startup Success”. Sharing his journey with Synendos Therapeutics AG.
Thank you @Innosuisse & @SGE for their continued support. We’re excited to be part of the Swiss delegation at #BIO2022 in San Diego on June 13-16, where we are looking forward to expanding our network of partners #biotech#CNS#neuroscience#endocannabinoid#SERIs@synendos
Looking for a pleasant reading for the weekend 📖? Then surf through our latest - and last! - @NCCR_TransCure newsletter! Learn about our "farewell fireworks" 🎆and further scientific news🔬from out network: https://t.co/DOxjfHc0XF
With the support of #InnoBoosterGRS, @AndreaChicca and his team at @synendos are developing breakthrough safe and effective therapies for neuropsychiatric disorders such as anxiety, mood and stress-related disorders.
@unibern
https://t.co/ZXCHgCxXnt
Accounting for 33% of exports, life science is a major business in Switzerland. Innovation is strongly powered by biotech startups.
Meet the 15 companies that scored in the TOP 100 Swiss Startup Award 2021:
https://t.co/oJ2Lh8ZdGc
#TOP100SSU#SwissStartups#Biotech
Synendos is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise.
#CNS#endocannabinoid#neurology#stressdisorders#neuropsychiatric
👉Full press release: https://t.co/SWQLHeli0J